Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
APApnimed, Inc. logo

Apnimed, Inc. (APMD)

NASDAQ · Currency in USD
$18.99 ▲ +0.46 (+2.48%)
At close: Oct 23, 4:00 PM ET. Market closed.
$18.90 ▼ -0.09 (-0.47%)
Pre-market: Oct 26, 7:15 AM ET

Summary

Previous Close
$18.53
Open
$18.50
Day's Range
$17.84 – $19.13
52 Week Range
$16.00 – $35.29
Volume
277,300
Avg. Volume
495,186
Market Cap
$790.57M
Beta (5Y Monthly)
0.00
PE Ratio (TTM)
--
EPS (TTM)
--
Earnings Date
Dec 8, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$60.00

Profile: Apnimed, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
81
CEO
Kevin R. Lind

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Earnings

Next report: Tue, Dec 8, 2026
EPS estimate -$0.64
DateEst.Actual
Sep 8, 2026-$0.49$3.92Beat

Analyst view

Consensus price target
$60.00 ▲ +216.0%
Range $60.00 – $60.00

Similar stocks

Get free alerts on APMD and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.